vs
爱德华生命科学（EW）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是RXO, Inc.的1.1倍（$1.6B vs $1.5B），爱德华生命科学净利率更高（23.1% vs -3.1%，领先26.2%），爱德华生命科学同比增速更快（16.7% vs -11.9%），过去两年RXO, Inc.的营收复合增速更高（26.8% vs 9.7%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
EW vs RXO — 直观对比
营收规模更大
EW
是对方的1.1倍
$1.5B
营收增速更快
EW
高出28.6%
-11.9%
净利率更高
EW
高出26.2%
-3.1%
两年增速更快
RXO
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.5B |
| 净利润 | $380.7M | $-46.0M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | -2.9% |
| 净利率 | 23.1% | -3.1% |
| 营收同比 | 16.7% | -11.9% |
| 净利润同比 | 6.8% | -84.0% |
| 每股收益（稀释后） | $0.66 | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRXO
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.4B | $1.0B | ||
| Q2 24 | $1.4B | $930.0M |
净利润EWRXO
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $-46.0M | ||
| Q3 25 | $291.1M | $-14.0M | ||
| Q2 25 | $333.2M | $-9.0M | ||
| Q1 25 | $358.0M | $-31.0M | ||
| Q4 24 | $385.6M | $-25.0M | ||
| Q3 24 | $3.1B | $-243.0M | ||
| Q2 24 | $366.3M | $-7.0M |
毛利率EWRXO
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWRXO
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | -2.9% | ||
| Q3 25 | 19.8% | -0.5% | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 27.9% | -2.1% | ||
| Q4 24 | 22.6% | -1.4% | ||
| Q3 24 | 25.9% | -1.9% | ||
| Q2 24 | 26.8% | — |
净利率EWRXO
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | -3.1% | ||
| Q3 25 | 18.7% | -1.0% | ||
| Q2 25 | 21.7% | -0.6% | ||
| Q1 25 | 25.3% | -2.2% | ||
| Q4 24 | 27.8% | -1.5% | ||
| Q3 24 | 226.7% | -23.4% | ||
| Q2 24 | 26.7% | -0.8% |
每股收益（稀释后）EWRXO
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $-0.28 | ||
| Q3 25 | $0.50 | $-0.08 | ||
| Q2 25 | $0.56 | $-0.05 | ||
| Q1 25 | $0.61 | $-0.18 | ||
| Q4 24 | $0.65 | $-0.17 | ||
| Q3 24 | $5.13 | $-1.81 | ||
| Q2 24 | $0.61 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $17.0M |
| 总债务越低越好 | — | $387.0M |
| 股东权益账面价值 | — | $1.5B |
| 总资产 | — | $3.3B |
| 负债/权益比越低杠杆越低 | — | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资EWRXO
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $17.0M | ||
| Q3 25 | $3.8B | $25.0M | ||
| Q2 25 | $4.1B | $18.0M | ||
| Q1 25 | $3.9B | $16.0M | ||
| Q4 24 | $4.0B | $35.0M | ||
| Q3 24 | $4.4B | $55.0M | ||
| Q2 24 | $2.0B | $7.0M |
总债务EWRXO
| Q1 26 | — | — | ||
| Q4 25 | — | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | — | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M |
股东权益EWRXO
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $1.5B | ||
| Q3 25 | $10.2B | $1.6B | ||
| Q2 25 | $10.5B | $1.6B | ||
| Q1 25 | $10.1B | $1.6B | ||
| Q4 24 | $10.0B | $1.6B | ||
| Q3 24 | $9.5B | $1.7B | ||
| Q2 24 | $7.4B | $579.0M |
总资产EWRXO
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $3.3B | ||
| Q3 25 | $13.3B | $3.2B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.0B | $3.3B | ||
| Q4 24 | $13.1B | $3.4B | ||
| Q3 24 | $13.0B | $3.4B | ||
| Q2 24 | $10.1B | $1.8B |
负债/权益比EWRXO
| Q1 26 | — | — | ||
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $7.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-9.0M |
| 自由现金流率自由现金流/营收 | — | -0.6% |
| 资本支出强度资本支出/营收 | — | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.0M |
8季度趋势，按日历期对齐
经营现金流EWRXO
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $7.0M | ||
| Q3 25 | $573.7M | $23.0M | ||
| Q2 25 | $290.2M | $23.0M | ||
| Q1 25 | $280.4M | $-2.0M | ||
| Q4 24 | $-127.5M | $-7.0M | ||
| Q3 24 | $351.8M | $-7.0M | ||
| Q2 24 | $371.5M | $-5.0M |
自由现金流EWRXO
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $-9.0M | ||
| Q3 25 | $516.2M | $9.0M | ||
| Q2 25 | $240.9M | $9.0M | ||
| Q1 25 | $224.4M | $-17.0M | ||
| Q4 24 | $-177.3M | $-19.0M | ||
| Q3 24 | $299.9M | $-18.0M | ||
| Q2 24 | $286.1M | $-16.0M |
自由现金流率EWRXO
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | -0.6% | ||
| Q3 25 | 33.2% | 0.6% | ||
| Q2 25 | 15.7% | 0.6% | ||
| Q1 25 | 15.9% | -1.2% | ||
| Q4 24 | -12.8% | -1.1% | ||
| Q3 24 | 22.1% | -1.7% | ||
| Q2 24 | 20.9% | -1.7% |
资本支出强度EWRXO
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 1.1% | ||
| Q3 25 | 3.7% | 1.0% | ||
| Q2 25 | 3.2% | 1.0% | ||
| Q1 25 | 4.0% | 1.0% | ||
| Q4 24 | 3.6% | 0.7% | ||
| Q3 24 | 3.8% | 1.1% | ||
| Q2 24 | 6.2% | 1.2% |
现金转化率EWRXO
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 0.87× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | -0.33× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
